Terms: = Colorectal cancer AND FH, HLRCC, 2271, ENSG00000091483, MCUL1, MCL, LRCC, P07954 AND Treatment
119 results:
1. Repurposing diacerein to suppress colorectal cancer growth by inhibiting the DCLK1/STAT3 signaling pathway.
Ye Q; Zhu Y; Shi M; Lv L; Gong Y; Zhang L; Yang L; Zhao H; Zhao C; Xu H
Chin J Nat Med; 2024 Apr; 22(4):318-328. PubMed ID: 38658095
[TBL] [Abstract] [Full Text] [Related]
2. [Incidence of postoperative complications in Chinese patients with gastric or colorectal cancer based on a national, multicenter, prospective, cohort study].
Zhang SQ; Wu ZQ; Huo BW; Xu HN; Zhao K; Jing CQ; Liu FL; Yu J; Li ZR; Zhang J; Zang L; Hao HK; Zheng CH; Li Y; Fan L; Huang H; Liang P; Wu B; Zhu JM; Niu ZJ; Zhu LH; Song W; You J; Yan S; Li ZY
Zhonghua Wei Chang Wai Ke Za Zhi; 2024 Mar; 27(3):247-260. PubMed ID: 38532587
[No Abstract] [Full Text] [Related]
3. BCL-X
Jenkins LJ; Luk IY; Chionh F; Tan T; Needham K; Ayton J; Reehorst CM; Vukelic N; Sieber OM; Mouradov D; Gibbs P; Williams DS; Tebbutt NC; Desai J; Hollande F; Dhillon AS; Lee EF; Merino D; Fairlie WD; Mariadason JM
Cell Death Dis; 2024 Mar; 15(3):183. PubMed ID: 38429301
[TBL] [Abstract] [Full Text] [Related]
4. The mechanism of anticancer effects of some pyrrolopyrimidine derivatives on HT-29 human colon cancer cells.
Ergul M; Kilic-Kurt Z; Aka Y; Kutuk O; Sahin-Inan ZD
Toxicol In Vitro; 2024 Mar; 95():105757. PubMed ID: 38061602
[TBL] [Abstract] [Full Text] [Related]
5. Dual targeting of mcl-1 and Bcl-2 to overcome chemoresistance in cervical and colon cancer.
Wang L; Xi C; Liu R; Ye T; Xiang N; Deng J; Li H
Anticancer Drugs; 2024 Mar; 35(3):219-226. PubMed ID: 37948336
[TBL] [Abstract] [Full Text] [Related]
6. P53‑microRNA interactions regulate the response of colorectal tumor cells to oxaliplatin under normoxic and hypoxic conditions.
Zhang J; Li C; Sun L; Sun D; Zhao T
Oncol Rep; 2023 Dec; 50(6):. PubMed ID: 37921068
[TBL] [Abstract] [Full Text] [Related]
7. Synthesis by diastereomeric resolution, biochemical evaluation and molecular modelling of chiral 3-hydroxyl b-lactam microtubule-targeting agents for the treatment of triple negative breast and chemoresistant colorectal cancers.
McLoughlin EC; Twamley B; O'Brien JE; Hannon Barroeta P; Zisterer DM; Meegan MJ; O'Boyle NM
Bioorg Chem; 2023 Dec; 141():106877. PubMed ID: 37804699
[TBL] [Abstract] [Full Text] [Related]
8. Domino Liver Transplantation for Unresectable Colon cancer Liver Metastasis From a Donor With Heterozygous Familial Hyperlipidemia: A Case Report.
Sambommatsu Y; Bruno DA; Imai D; Lee SD; Khan AA; Sharma A; Saeed M; Cotterell AH; Levy MF; Bhati C; Kumaran V
Transplant Proc; 2023 Oct; 55(8):1930-1933. PubMed ID: 37661467
[TBL] [Abstract] [Full Text] [Related]
9. Sphingosine kinase-2 silencing modulates sensitivity of HT-29 human colorectal cancer cells to paclitaxel-induced cell death through altering apoptosis-related proteins.
Mu Y; Wang J; Li G
Chem Biol Drug Des; 2023 Aug; 102(2):255-261. PubMed ID: 36929215
[TBL] [Abstract] [Full Text] [Related]
10. STAT3 regulates 5-Fu resistance in human colorectal cancer cells by promoting mcl-1-dependent cytoprotective autophagy.
Yue Y; Zhang Q; Wang X; Sun Z
Cancer Sci; 2023 Jun; 114(6):2293-2305. PubMed ID: 36788743
[TBL] [Abstract] [Full Text] [Related]
11. Combined inhibition of aurora kinases and Bcl-xL induces apoptosis through select BH3-only proteins.
Li J; Chen CH; O'Neill KL; Fousek-Schuller VJ; Black AR; Black JD; Zhang J; Luo X
J Biol Chem; 2023 Feb; 299(2):102875. PubMed ID: 36621626
[TBL] [Abstract] [Full Text] [Related]
12. Locoregionally Recurrent Colon cancer: How Far Have We Come? A Population-Based, Retrospective Cohort Study.
Swartjes H; van Lankveld DWP; van Erning FN; Verheul HMW; de Wilt JHW; Koëter T; Vissers PAJ
Ann Surg Oncol; 2023 Mar; 30(3):1726-1734. PubMed ID: 36261752
[TBL] [Abstract] [Full Text] [Related]
13. BCAP31 is involved in modulating colorectal cancer cell proliferation via the Emerin/β-catenin axis.
Han L; Shi J; Zhao L; Deng J; Li Y; Zhao H; Wang H; Yan Y; Zou F
Exp Cell Res; 2022 Sep; 418(1):113265. PubMed ID: 35716785
[TBL] [Abstract] [Full Text] [Related]
14. Tannic acid attenuate AKT phosphorylation to inhibit UMUC3 bladder cancer cell proliferation.
Chen MC; Annseles Rajula S; Bharath Kumar V; Hsu CH; Day CH; Chen RJ; Wang TF; Viswanadha VP; Li CC; Huang CY
Mol Cell Biochem; 2022 Dec; 477(12):2863-2869. PubMed ID: 35691981
[TBL] [Abstract] [Full Text] [Related]
15. FL118, acting as a 'molecular glue degrader', binds to dephosphorylates and degrades the oncoprotein DDX5 (p68) to control c-Myc, survivin and mutant Kras against colorectal and pancreatic cancer with high efficacy.
Ling X; Wu W; Aljahdali IAM; Liao J; Santha S; Fountzilas C; Boland PM; Li F
Clin Transl Med; 2022 May; 12(5):e881. PubMed ID: 35604033
[TBL] [Abstract] [Full Text] [Related]
16. mcl-1 levels critically impact the sensitivities of human colorectal cancer cells to APG-1252-M1, a novel Bcl-2/Bcl-X
Yao W; Bai L; Wang S; Zhai Y; Sun SY
Neoplasia; 2022 Jul; 29():100798. PubMed ID: 35462114
[TBL] [Abstract] [Full Text] [Related]
17. The Interaction Between cancer-associated Fibroblasts and cancer Cells Enhances Bcl-xL and mcl-1 in colorectal cancer.
Maeda A; Takahashi H; Harata S; Watanabe K; Yanagita T; Suzuki T; Ushigome H; Nakai N; Maeda Y; Hirokawa T; Shiga K; Ogawa R; Hara M; Matsuo Y; Mitsui A; Kimura M; Takiguchi S
Anticancer Res; 2022 Mar; 42(3):1277-1288. PubMed ID: 35220217
[TBL] [Abstract] [Full Text] [Related]
18. Bcl-2/Bcl-xL inhibitor ABT-263 overcomes hypoxia-driven radioresistence and improves radiotherapy.
Ritter V; Krautter F; Klein D; Jendrossek V; Rudner J
Cell Death Dis; 2021 Jul; 12(7):694. PubMed ID: 34257274
[TBL] [Abstract] [Full Text] [Related]
19. Irreversible JNK blockade overcomes PD-L1-mediated resistance to chemotherapy in colorectal cancer.
Sun L; Patai ÁV; Hogenson TL; Fernandez-Zapico ME; Qin B; Sinicrope FA
Oncogene; 2021 Aug; 40(32):5105-5115. PubMed ID: 34193942
[TBL] [Abstract] [Full Text] [Related]
20. BH3 Mimetic Sensitivity of colorectal cancer Cell Lines in Correlation with Molecular Features Identifies Predictors of Response.
Zhang L; Ramesh P; Steinmetz M; Medema JP
Int J Mol Sci; 2021 Apr; 22(8):. PubMed ID: 33917026
[TBL] [Abstract] [Full Text] [Related]
[Next]
